Literature summary extracted from
Arnoldi, A.; Crimella, C.; Tenderini, E.; Martinuzzi, A.; D'Angelo, M.G.; Musumeci, O.; Toscano, A.; Scarlato, M.; Fantin, M.; Bresolin, N.; Bassi, M.T.
Clinical phenotype variability in patients with hereditary spastic paraplegia type 5 associated with CYP7B1 mutations (2012), Clin. Genet., 81, 150-157.
Cloned(Commentary)
EC Number |
Cloned (Comment) |
Organism |
---|
1.14.14.29 |
CYP7B1 genotyping and screening for CYP7B1 mutations in a large cohort of 105 Italian HSP index patients, including 50 patients with a complicated phenotype and 55 with a pure form, overall mutation frequencies of CYP7B1, overview |
Homo sapiens |
Protein Variants
EC Number |
Protein Variants |
Comment |
Organism |
---|
1.14.14.29 |
G443A |
c.1328G-C, naturally occuring mutation of CYP7B1 involved in spastic paraplegia type 5 |
Homo sapiens |
1.14.14.29 |
G87V |
c.260G-T, naturally occuring mutation of CYP7B1 involved in spastic paraplegia type 5 |
Homo sapiens |
1.14.14.29 |
H285L |
c.854A-T, naturally occuring mutation of CYP7B1 involved in spastic paraplegia type 5 |
Homo sapiens |
1.14.14.29 |
R324H |
c.971G-A, naturally occuring mutation of CYP7B1 involved in spastic paraplegia type 5 |
Homo sapiens |
Organism
EC Number |
Organism |
UniProt |
Comment |
Textmining |
---|
1.14.14.29 |
Homo sapiens |
O75881 |
gene Cyp7B1 |
- |
Synonyms
EC Number |
Synonyms |
Comment |
Organism |
---|
1.14.14.29 |
CYP7B1 |
- |
Homo sapiens |
1.14.14.29 |
cytochrome P-450 oxysterol 7-alpha-hydroxylase |
- |
Homo sapiens |
General Information
EC Number |
General Information |
Comment |
Organism |
---|
1.14.14.29 |
metabolism |
CYP7B1 is an enzyme expressed in many human tissues and implicated in cholesterol metabolism. In the liver, this protein is part of the alternate/acidic pathway for primary bile acid production while in brain, CYP7B1 provides the primary metabolic route for cholesterol derivatives dehydroepiandrosterone and related hydroxysteroids via 7alpha-hydroxylation |
Homo sapiens |
1.14.14.29 |
additional information |
spastic paraplegia type 5, SPG5, is caused by mutations in CYP7B1, a gene encoding the cytochrome P-450 oxysterol 7-alpha-hydroxylase, CYP7B1, an enzyme implicated in cholesterol metabolism. Mutations in CYP7B1 are found in both pure and complicated forms of the disease, clinical phenotypes, overview |
Homo sapiens |